glutamine has been researched along with Leukemia, T-Cell in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, C; Cui, C; Dou, QP; Fan, Y; Xiao, Y; Zhang, X | 1 |
| Eibl, G; Enrich, B; Herold, M; Kircher, B; Lätzer, K; Niederwieser, D | 1 |
| Calvani, M; Conti, F; Manetti, C; Miccheli, A; Peluso, G; Puccetti, C; Tomassini, A; Tuccillo, F; Valerio, M | 1 |
| Fumarola, C; Guidotti, GG; Zerbini, A | 1 |
4 other study(ies) available for glutamine and Leukemia, T-Cell
| Article | Year |
|---|---|
L-glutamine Schiff base copper complex as a proteasome inhibitor and an apoptosis inducer in human cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Proliferation; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Female; Glutamine; Humans; I-kappa B Proteins; Jurkat Cells; Kinetics; Leukemia, T-Cell; NF-KappaB Inhibitor alpha; Organometallic Compounds; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Ubiquitin | 2008 |
The role of L-alanyl-L-glutamine in the immune response in vitro.
Topics: Cytokines; Cytotoxicity, Immunologic; Dipeptides; Dose-Response Relationship, Drug; Glutamine; Humans; Immune Tolerance; Immunity, Cellular; In Vitro Techniques; K562 Cells; Killer Cells, Natural; Leukemia, T-Cell; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Parenteral Nutrition; Stimulation, Chemical; T-Lymphocytes; T-Lymphocytes, Cytotoxic; Tumor Cells, Cultured | 2002 |
Metabolic profiling by 13C-NMR spectroscopy: [1,2-13C2]glucose reveals a heterogeneous metabolism in human leukemia T cells.
Topics: Carbon Isotopes; Cell Cycle; Cell Proliferation; Citric Acid Cycle; Glucose; Glutamine; Glycine; Humans; Jurkat Cells; Lactic Acid; Leukemia, T-Cell; Magnetic Resonance Spectroscopy; Models, Biological; Nucleotides; Pentose Phosphate Pathway; Pentoses; Serine | 2006 |
Glutamine deprivation-mediated cell shrinkage induces ligand-independent CD95 receptor signaling and apoptosis.
Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents; Apoptosis; Asparaginase; Carrier Proteins; Cell Membrane; Cell Size; Clone Cells; Culture Media; Fas Ligand Protein; fas Receptor; Fas-Associated Death Domain Protein; Glutamine; HL-60 Cells; Humans; Kinetics; Leukemia, T-Cell; Membrane Glycoproteins; Mutation; Signal Transduction; Tumor Cells, Cultured | 2001 |